Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

dual tasking

- PMLiVE

A little less conversation

Patient centricity - easy to say, hard to do

- PMLiVE

‘Flexible working’: fashionable buzzword or fundamental business operation?

Can flexible working go a long way to fulfilling everyone’s personal and business goals?

- PMLiVE

Encouraging data for Roche flu drug ahead of FDA decision

Trial looks at benefts in high risk groups

Roche Basel Switzerland

Roche drug hits the mark in spinal muscular atrophy studies

Data suggests Risdiplam could improve motor function

- PMLiVE

FCB Health expands into Germany

Joerg Hempelmann announces the launch of FCB Health Frankfurt

- PMLiVE

New starters join Four Communications, Emotive and McCann Health

The latest movers in healthcare communications

- PMLiVE

Apple Watch Series 4: A life-saving tool or just making us more health obsessed?

Apple’s latest Watch boasts lots of new health and fitness features. But are these really beneficial? Or are they just making us more health obsessed?

Page & Page Health

Eli Lilly HQ

Lilly gets EMA nod for Verzenio in breast cancer

And puts pressure on Pfizer’s market leading Ibrance and Novartis’ Kisqali

- PMLiVE

Hancock says UK genome service is now ‘rolling out’

Health secretary also announces a £240m social care boost

- PMLiVE

GSK to reverse ‘no KOLs’ policy, admitting it has hit marketing

Company seeking to revive lacklustre marketing performance

- PMLiVE

UK government’s low-skill migration plans ‘will hit social care’

Warnings of impact across economy

- PMLiVE

Janssen’s single tablet Symtuza gains NHS England funding 

Janssen and Gilead combination first to reach patients

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links